baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Merck & Co Inc/ US58933Y1055 /

2024-05-08 9:59:56 PM	Chg. -0.83	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
129.54USD	-0.64%	145,932 Turnover: 18.96 mill.	-Bid Size: -	-Ask Size: -	328.13 bill.USD	2.28%	925.36

GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...

GlobeNewswire 05-08 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02-02 Merck Group to expand investment in South Korea

TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B

TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 2023-12-19 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 2023-12-12 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 2023-12-05 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

GlobeNewswire 2023-12-04 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule

GlobeNewswire 2023-11-13 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B

TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs

Merck & Co Inc/ US58933Y1055 /

If you wish to receive reply to your feedback, please provide your email address.